Cidara Therapeutics Target Price

See how CDTX's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$221.38

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2025-11-14	RBC Capital	$221.5	0.1% upside
2025-10-09	H.C. WainwrightSara Nik	$150	32.2% downside
2025-10-03	JMP Securities	$173	21.9% downside
2025-09-26	H.C. Wainwright	$110	50.3% downside
2025-09-24	JMP SecuritiesRoy Buchanan	$153	30.9% downside
2025-09-24	GuggenheimSeamus Fernandez	$167	24.6% downside
2025-09-24	RBC CapitalBrian Abrahams	$137	38.1% downside
2025-07-09	GuggenheimSeamus Fernandez	$69	68.8% downside
2025-06-24	Guggenheim	$68	69.3% downside
2025-05-16	GuggenheimSeamus Fernandez	$50	77.4% downside
2025-03-12	JMP SecuritiesRoy Buchanan	$46	79.2% downside
2024-08-14	H.C. WainwrightEd Arce	$12	94.6% downside

Cidara Therapeutics (CDTX) FAQ

Stockcircle tracks target price for Cidara Therapeutics (CDTX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Cidara Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main CDTX overview so you can move from this figure to the surrounding analysis quickly.